Stock Market News

Eli Lilly nears $1.3 billion deal for gene-editing biotech Verve Therapeutics, FT reports

Jun 17, 2025 - 01:02
 0
Eli Lilly nears $1.3 billion deal for gene-editing biotech Verve Therapeutics, FT reports
Read More

Tags:

Previous Article

Eli Lilly close to buying gene editing firm Verve for $1.3 bln- FT

Next Article

JPMorgan files ‘JPMD’ trademark for crypto payment services

Related Posts

Goldman Sachs initiates coverage on generic drugmakers, sees upside in Teva and Am

Goldman Sachs initiates coverage on generic drugmakers,...

Jun 6, 2025  0

FTSE 100 today: Index flat ahead of U.S.-China talks in London; WPP CEO to retire

FTSE 100 today: Index flat ahead of U.S.-China talks in...

Jun 9, 2025  0

Europe's AI computing capacity to grow tenfold in two y...

Jun 11, 2025  0